https://doi.org/10.4081/monaldi.2020.1224
Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose
Submitted: January 1, 2020
Accepted: February 4, 2020
Published: March 20, 2020
Accepted: February 4, 2020
Abstract Views: 1264
PDF: 784
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
We present the case of a 80-year-old man with atrial fibrillation, morbid obesity (weight 123 kg, height 167 cm, BMI 44.1), high clearance of creatinine and pharmacological polytherapy, in which the serial determinations of edoxaban plasma levels help us to choose the appropriate dose.
How to Cite
Russo, Vincenzo, Anna Rago, Nunzia Laezza, Pierpaolo Di Micco, Laura Giannetti, Luigi Atripaldi, Antonio D’Onofrio, Paolo Golino, and Gerardo Nigro. 2020. “Edoxaban in Elderly Patient With Morbid Obesity and Atrial Fibrillation: The Role of Plasma Levels Evaluation for Selecting the Appropriate Dose”. Monaldi Archives for Chest Disease 90 (1). https://doi.org/10.4081/monaldi.2020.1224.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Cesare Greco, Rivaroxaban in non valvular atrial fibrillation: subgroups analysis , Monaldi Archives for Chest Disease: Vol. 82 No. 1 (2014): Cardiac series
- Donatella Del Sindaco, Maria Denitza Tinti, Giovanni Pulignano, Stefano Tolone, Giovanni Minardi, Massimo Uguccioni, Antonio Lax, Cardiac rehabilitation is safe and effective also in the elderly, but don't forget about drugs! , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- Pasqualina Calisi, Raffaele Griffo, Postoperative atrial fibrillation: etiopathogenesis, prevention and therapy , Monaldi Archives for Chest Disease: Vol. 62 No. 2 (2004): Cardiac series
- Gian Francesco Mureddu, Arterial hypertension. Does the J curve exist? And then? , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- P. KovaÄević, M. Stanetić, Z. RajkovaÄa, S. Veljković, M. Kojicic, F. Joachim Meyer, The correlation between endothelin-1 levels and spirometry in dialysis patients compared to healthy subjects , Monaldi Archives for Chest Disease: Vol. 79 No. 2 (2013): Pulmonary series
- Roberto Cemin, Massimiliano Manfrin, Massimo Daves, Werner Rauhe, Aldo Pietro Maggioni, Ten years differences in recently onset atrial fibrillation and flutter incidence and management , Monaldi Archives for Chest Disease: Vol. 82 No. 3 (2014): Cardiac series
- Teresa Cascella, Francesco Giallauria, Domenico Tafuri, Gaetano Lombardi, Annamaria Colao, Carlo Vigorito, Francesco Orio, Cardiovascular complications of obesity , Monaldi Archives for Chest Disease: Vol. 66 No. 4 (2006): Cardiac series
- Gian Francesco Mureddu, Arterial hypertension: which targets in over-75-year people? , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- Giampaolo Scorcu, Annarita Pilleri, Treatment of heart failure in the elderly: Which drugs are essential and which should be avoided , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- A. van Huisstede, G.J. Braunstahl, Obesity and asthma: co-morbidity or causal relationship? , Monaldi Archives for Chest Disease: Vol. 73 No. 3 (2010): Pulmonary series
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
